Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter C. Brandt currently holds 95,181 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter C. Brandt has been a net buyer of RNN stock. They have purchased $1.3M and sold $0 worth of shares.
Peter C. Brandt's most recent insider trade was on Dec 22, 2025, when they sold 72,464 shares at $1.38 per share.
Peter C. Brandt serves as Executive at REXAHN PHARMACEUTICALS, INC. (RNN). They have executed 57 insider transactions totaling $1.3M over their tenure at the company.
Peter C. Brandt holds the position of Executive at REXAHN PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Peter C. Brandt has shown a buying trading pattern, with $1.3M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter C. Brandt was on Aug 27, 2009, when they sold $3.0M worth of NOVN shares. This transaction involved 183,333 shares at $16.50 per share.
Peter C. Brandt currently owns 95,181 shares of REXAHN PHARMACEUTICALS, INC. (RNN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter C. Brandt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter C. Brandt has 57 Form 4 filings on record as an insider at REXAHN PHARMACEUTICALS, INC..
Set alerts for Peter C. Brandt and 40,000+ other insiders.